Notice of Closed Meeting, 3452 [2019-01959]
Download as PDF
<![CDATA[
3452
Federal Register / Vol. 84, No. 29 / Tuesday, February 12, 2019 / Notices
You may submit comments,
identified by Docket No. CDC–2019–
0008 by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
Mailstop H16–4, Atlanta, Georgia 30329;
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: For
questions concerning this notice: Ashley
C. Altenburger, JD, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop H16–4, Atlanta,
Georgia 30329; telephone 404–498–
1600; email dgmqpolicyoffice@cdc.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data.
Please note that comments received,
including attachments and other
supporting materials, are part of the
public record and are subject to public
disclosure. Comments will be posted on
https://www.regulations.gov. Therefore,
do not include any information in your
comment or supporting materials that
you consider confidential or
inappropriate for public disclosure. If
you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be on
public display. CDC will review all
submissions and may choose to redact,
or withhold, submissions containing
private or proprietary information such
as Social Security numbers, medical
information, inappropriate language, or
duplicate/near duplicate examples of a
mass-mail campaign.
Additional Background
HHS/CDC published the final rule for
the Control of Communicable Diseases
on January 19, 2017, which included
amendments to the domestic (interstate)
and foreign quarantine regulations for
the control of communicable diseases.
The rule became effective on March 21,
2017. CDC regulations at 42 CFR 71.4
(airlines) and 42 CFR 71.5 (vessels)
relate to the transmission of passenger,
crew, and flight/voyage information for
public health purposes; both contain
subsections that state:
VerDate Sep<11>2014
18:30 Feb 11, 2019
Jkt 247001
No later than February 21, 2019, the
Secretary or Director will publish and
seek comment on a report evaluating
the burden of this section on affected
entities and duplication of activities in
relation to mandatory passenger data
submissions to [U.S. Department of
Homeland Security, Customs and
Border Patrol] DHS/CBP. The report will
specifically recommend actions that
streamline and facilitate use and
transmission of any duplicate
information collected.
On February 12, 2019, CDC published
a report to its website evaluating the
burdens these regulatory provisions may
have generated on the airline and ship
industries since they became effective
on March 21, 2017. The report can be
found at https://www.cdc.gov/
quarantine/final-rule-communicablediseases.html. The public comment
period will end on March 14, 2019.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2019–02035 Filed 2–11–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—DD19–001; Research
Approaches to Improve the Care and
Outcomes of People Living with Spina Bifida
Components A and B.
Dates: April 9–10, 2019.
Times: 10:00 a.m.–6:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
For Further Information Contact: Jaya
Raman, Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop F80,
Atlanta, Georgia 30341, Telephone: (770)
488–6511, kva5@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–01959 Filed 2–11–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2019–0007]
The National Healthcare Safety
Network’s Outpatient Procedure
Component (OPC) Surveillance
Protocol and the Bloodstream
Infection (BSI) Surveillance Protocol;
Request for Information
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Request for information.
AGENCY:
The Centers for Disease
Control and Prevention, in the
Department of Health and Human
Services, seeks information related to
the surveillance protocols for the
National Healthcare Safety Network’s
(NHSN) Outpatient Procedure
Component (OPC) and Bloodstream
Infection (BSI) Module of the Patient
Safety Component. CDC is opening this
docket to provide the opportunity to
identify issues and areas for potential
improvement for consideration as CDC
updates and maintains the NHSN
surveillance protocols beginning in
2020.
SUMMARY:
Written comments will be
accepted beginning February 14, 2019
and must be received on or before April
15, 2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
xxxx, by either of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Katherine Allen-Bridson,
National Center for Emerging and
DATES:
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 84, Number 29 (Tuesday, February 12, 2019)]
[Notices]
[Page 3452]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01959]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Chief Operating
Officer, CDC, pursuant to Public Law 92-463. The grant applications and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--DD19-001; Research
Approaches to Improve the Care and Outcomes of People Living with
Spina Bifida Components A and B.
Dates: April 9-10, 2019.
Times: 10:00 a.m.-6:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Jaya Raman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and
Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01959 Filed 2-11-19; 8:45 am]
BILLING CODE 4163-18-P
